125 related articles for article (PubMed ID: 10725785)
1. Influence of IGF-I and cell density on MDR1 expression in the T-lymphoblastoid cell line CCRF-CEM.
Schwarze CP; Neu S; Beck J; Mavridou K; Ranke MB; Binder G
Horm Res; 1999; 52(4):192-9. PubMed ID: 10725785
[TBL] [Abstract][Full Text] [Related]
2. Induction of multidrug resistance in MOLT-4 cells by anticancer agents is closely related to increased expression of functional P-glycoprotein and MDR1 mRNA.
Liu ZL; Onda K; Tanaka S; Toma T; Hirano T; Oka K
Cancer Chemother Pharmacol; 2002 May; 49(5):391-7. PubMed ID: 11976833
[TBL] [Abstract][Full Text] [Related]
3. Anticancer drug-mediated induction of multidrug resistance-associated genes and protein kinase C isozymes in the T-lymphoblastoid cell line CCRF-CEM and in blasts from patients with acute lymphoblastic leukemias.
Beck JF; Brügger D; Brischwein K; Liu C; Bader P; Niethammer D; Gekeler V
Jpn J Cancer Res; 2001 Aug; 92(8):896-903. PubMed ID: 11509123
[TBL] [Abstract][Full Text] [Related]
4. Mdr1/P-glycoprotein, topoisomerase, and glutathione-S-transferase pi gene expression in primary and relapsed state adult and childhood leukaemias.
Gekeler V; Frese G; Noller A; Handgretinger R; Wilisch A; Schmidt H; Muller CP; Dopfer R; Klingebiel T; Diddens H
Br J Cancer; 1992 Sep; 66(3):507-17. PubMed ID: 1355660
[TBL] [Abstract][Full Text] [Related]
5. Overexpression of SORCIN is a Prognostic Biomarker for Multidrug-Resistant Pediatric Acute Lymphoblastic Leukemia and Correlates with Upregulated MDR1/P-gp.
Dabaghi M; Rahgozar S; Moshtaghian J; Moafi A; Abedi M; Pourabutaleb E
Genet Test Mol Biomarkers; 2016 Sep; 20(9):516-21. PubMed ID: 27382961
[TBL] [Abstract][Full Text] [Related]
6. [Quantitative analysis of multidrug resistance phenotype in hematological malignancies].
Kobayashi H; Takemura Y
Rinsho Byori; 1998 Apr; 46(4):380-90. PubMed ID: 9594630
[TBL] [Abstract][Full Text] [Related]
7. Induction of MDR1 gene expression by anthracycline analogues in a human drug resistant leukaemia cell line.
Hu XF; Slater A; Rischin D; Kantharidis P; Parkin JD; Zalcberg J
Br J Cancer; 1999 Feb; 79(5-6):831-7. PubMed ID: 10070877
[TBL] [Abstract][Full Text] [Related]
8. Quantitative analysis of human multidrug resistance 1 (MDR1) gene expression by nonisotopic competitive reverse transcriptase polymerase chain reaction assay.
Kobayashi H; Takemura Y; Miyachi H; Kawabata M; Mori S; Kawai Y; Furihata K; Sekiguchi S; Watanabe K
J Clin Lab Anal; 1997; 11(5):258-66. PubMed ID: 9292393
[TBL] [Abstract][Full Text] [Related]
9. Activity of drugs from traditional Chinese medicine toward sensitive and MDR1- or MRP1-overexpressing multidrug-resistant human CCRF-CEM leukemia cells.
Efferth T; Davey M; Olbrich A; Rücker G; Gebhart E; Davey R
Blood Cells Mol Dis; 2002; 28(2):160-8. PubMed ID: 12064912
[TBL] [Abstract][Full Text] [Related]
10. Influence of combinations of digitonin with selected phenolics, terpenoids, and alkaloids on the expression and activity of P-glycoprotein in leukaemia and colon cancer cells.
Eid SY; El-Readi MZ; Eldin EE; Fatani SH; Wink M
Phytomedicine; 2013 Dec; 21(1):47-61. PubMed ID: 23999162
[TBL] [Abstract][Full Text] [Related]
11. Drug-induced changes in the expression of MDR-associated genes: investigations on cultured cell lines and chemotherapeutically treated leukemias.
Gekeler V; Beck J; Noller A; Wilisch A; Frese G; Neumann M; Handgretinger R; Ehninger G; Probst H; Niethammer D
Ann Hematol; 1994; 69 Suppl 1():S19-24. PubMed ID: 7914748
[TBL] [Abstract][Full Text] [Related]
12. The role of c-myc in regulating mdr1 gene expression in tumor cell line KB.
He Y; Zhang J; Zhang J; Yuan Y
Chin Med J (Engl); 2000 Sep; 113(9):848-51. PubMed ID: 11776085
[TBL] [Abstract][Full Text] [Related]
13. Semi-quantitative RT-PCR method to estimate full-length mRNA levels of the multidrug resistance gene.
Yang Z; Woodahl EL; Wang XY; Bui T; Shen DD; Ho RJ
Biotechniques; 2002 Jul; 33(1):196, 198, 200 passim. PubMed ID: 12139246
[TBL] [Abstract][Full Text] [Related]
14. Atypical multi-drug resistance (MDR): low sensitivity of a P-glycoprotein-expressing human T lymphoblastoid MDR cell line to classical P-glycoprotein-directed resistance-modulating agents.
Jachez B; Loor F
Anticancer Drugs; 1993 Dec; 4(6):605-15. PubMed ID: 7905300
[TBL] [Abstract][Full Text] [Related]
15. [CIK cells acquired multidrug resistance and maintained cytotoxic activity to tumor cells after mdr1 gene transfection].
Yang YH; Li HF; Shi YJ; Wang YQ; Zhang Y; Wang YJ; Zhu P
Zhonghua Xue Ye Xue Za Zhi; 2003 Dec; 24(12):617-20. PubMed ID: 14761606
[TBL] [Abstract][Full Text] [Related]
16. [Mechanisms of multidrug resistance in tumor cells and analytical methods for its detection].
Takemura Y; Kobayashi H; Miyachi H
Rinsho Byori; 1998 Aug; 46(8):745-58. PubMed ID: 9760826
[TBL] [Abstract][Full Text] [Related]
17. Aspirin enhances multidrug resistance gene 1 expression in human Molt-4 T lymphoma cells.
Flescher E; Rotem R; Kwon P; Azare J; Jaspers I; Cohen D
Anticancer Res; 2000; 20(6B):4441-4. PubMed ID: 11205285
[TBL] [Abstract][Full Text] [Related]
18. Expression levels of human P-glycoprotein in in vitro cell lines: correlation between mRNA and protein levels for P-glycoprotein expressed in cells.
Shirasaka Y; Konishi R; Funami N; Kadowaki Y; Nagai Y; Sakaeda T; Yamashita S
Biopharm Drug Dispos; 2009 Apr; 30(3):149-52. PubMed ID: 19243013
[TBL] [Abstract][Full Text] [Related]
19. Reversal of P-glycoprotein-mediated multidrug resistance with small interference RNA (siRNA) in leukemia cells.
Peng Z; Xiao Z; Wang Y; Liu P; Cai Y; Lu S; Feng W; Han ZC
Cancer Gene Ther; 2004 Nov; 11(11):707-12. PubMed ID: 15375375
[TBL] [Abstract][Full Text] [Related]
20. RNA expression of MDR1/P-glycoprotein, DNA-topoisomerase I, and MRP2 in ovarian carcinoma patients: correlation with chemotherapeutic response.
Materna V; Pleger J; Hoffmann U; Lage H
Gynecol Oncol; 2004 Jul; 94(1):152-60. PubMed ID: 15262134
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
